Maria Palasis
2020
In 2020, Maria Palasis earned a total compensation of $4.3M as President and Chief Executive Officer at Lyra Therapeutics, a 410% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $275,000 |
|---|---|
| Option Awards | $3,547,671 |
| Salary | $470,520 |
| Other | $8,550 |
| Total | $4,301,741 |
Palasis received $3.5M in option awards, accounting for 82% of the total pay in 2020.
Palasis also received $275K in non-equity incentive plan, $470.5K in salary and $8.6K in other compensation.
Rankings
In 2020, Maria Palasis' compensation ranked 2,642nd out of 13,090 executives tracked by ExecPay. In other words, Palasis earned more than 79.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,642 out of 13,090 | 80th |
Division Manufacturing | 1,016 out of 5,624 | 82nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 115 out of 799 | 86th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 66 out of 495 | 87th |
Industry Surgical and Medical Instruments and Apparatus | 46 out of 313 | 85th |
Source: SEC filing on April 14, 2021.
Palasis' colleagues
We found two more compensation records of executives who worked with Maria Palasis at Lyra Therapeutics in 2020.